Nancy Gin, MD, FACP, is executive vice president of Quality and chief quality officer for The Permanente Federation, overseeing clinical quality and safety for 23,982 physicians nationwide in 8 Kaiser Permanente regions from Hawaii to the Mid-Atlantic States and 12.7 million members. Her responsibilities include leading the National Permanente Quality Leaders and co-leading the Kaiser Permanente National Quality Committee, developing a national quality strategy, and ensuring alignment and consistency of care and outcomes among Kaiser Permanente regions.
She also serves as the medical director of Quality and Clinical Analysis for the Southern California Permanente Medical Group. She oversees SCPMG’s research and evaluation and continuing medical education nationally.
Dr. Gin has also participated in the U.S. Department of Health and Human Services Health Quality Summit and the Task Force on Telehealth Policy, a partnership of National Committee for Quality Assurance, American Telemedicine Association, and Alliance for Connected Care; and sits on the Standards Committee for the NCQA.
Prior to these roles, Dr. Gin served as the medical director and chief of staff for Kaiser Permanente Orange County. She has more than 30 years of internal medicine expertise and leadership experience. She was instrumental in the development and opening of the Kaiser Permanente Orange County-Irvine Medical Center in 2008.
Dr. Gin joined SCPMG in 1997 following her tenure on the clinical faculty of the University of California, Irvine College of Medicine.
She is board certified in internal medicine and is a member of the California Medical Association and fellow of the American College of Physicians. Dr. Gin earned her Bachelor of Science and medical degree from the University of Arizona, and completed her internship, residency, and fellowship in internal medicine at the University of California, Irvine.
She is a well-respected clinician who has co-authored and published clinical papers and book chapters on topics including domestic violence, hypertension, and health policy in bioethics. She is an advocate for public service and equity in health care, and a dedicated educator, recognized with several awards for teaching and outstanding academic contributions. In 2022, she was named one of Modern Healthcare’s Top 25 Innovators.